APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cisatracurium Besylate Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cisatracurium Besylate Injection Industry Growth and Trends Forecast to 2032

2 January 2026109 pages

Choose your research edition.

Industry ResearchCisatracurium Besylate Injection Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Cisatracurium Besylate Injection Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Cisatracurium Besylate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cisatracurium Besylate Injection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cisatracurium Besylate Injection Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Cisatracurium Besylate Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cisatracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cisatracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cisatracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cisatracurium Besylate Injection include Meitheal Pharmaceuticals, AbbVie, Fresenius Kabi, Pfizer, Jiangsu Singchn, Sandoz, Shanghai Sino Biopharma, Shanghai Hengrui Pharmaceutical and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cisatracurium Besylate Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cisatracurium Besylate Injection market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cisatracurium Besylate Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cisatracurium Besylate Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cisatracurium Besylate Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cisatracurium Besylate Injection Market by Company

Meitheal Pharmaceuticals

AbbVie

Fresenius Kabi

Pfizer

Jiangsu Singchn

Sandoz

Shanghai Sino Biopharma

Shanghai Hengrui Pharmaceutical

Teva

Xianju Pharma

Cisatracurium Besylate Injection Segment by Type

2 mg/mL

5 mg/mL

10 mg/mL

Cisatracurium Besylate Injection Segment by Application

Clinics

Hospital

Recovery Center

Cisatracurium Besylate Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cisatracurium Besylate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cisatracurium Besylate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cisatracurium Besylate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cisatracurium Besylate Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cisatracurium Besylate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 2 mg/mL Table 2. Major Company of 5 mg/mL Table 3. Major Company of 10 mg/mL Table 4. Global Cisatracurium Besylate Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cisatracurium Besylate Injection Sales by Type (2021-2026) & (W Units) Table 6. Global Cisatracurium Besylate Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Cisatracurium Besylate Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Cisatracurium Besylate Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global Cisatracurium Besylate Injection Price by Type (2021-2026) & (US$/Unit) Table 10. Global Cisatracurium Besylate Injection Sales by Type (2027-2032) & (W Units) Table 11. Global Cisatracurium Besylate Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Cisatracurium Besylate Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Cisatracurium Besylate Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global Cisatracurium Besylate Injection Price by Type (2027-2032) & (US$/Unit) Table 15. North America Cisatracurium Besylate Injection Sales by Type (2021-2026) & (W Units) Table 16. North America Cisatracurium Besylate Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Cisatracurium Besylate Injection Sales by Type (2021-2026) & (W Units) Table 18. Europe Cisatracurium Besylate Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Cisatracurium Besylate Injection Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Cisatracurium Besylate Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Cisatracurium Besylate Injection Sales by Type (2021-2026) & (W Units) Table 22. Latin America Cisatracurium Besylate Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Cisatracurium Besylate Injection Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Cisatracurium Besylate Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Cisatracurium Besylate Injection Industry Trends Table 26. Cisatracurium Besylate Injection Industry Drivers Table 27. Cisatracurium Besylate Injection Industry Opportunities and Challenges Table 28. Cisatracurium Besylate Injection Industry Restraints Table 29. Global Cisatracurium Besylate Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Cisatracurium Besylate Injection Revenue Market Share by Company (2021-2026) Table 31. Global Cisatracurium Besylate Injection Sales by Company (2021-2026) & (W Units) Table 32. Global Cisatracurium Besylate Injection Sales Share by Company (2021-2026) Table 33. Global Cisatracurium Besylate Injection Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Cisatracurium Besylate Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Cisatracurium Besylate Injection Major Company Production Sites and Headquarters Table 36. Global Cisatracurium Besylate Injection Company, Product Type & Application Table 37. Global Cisatracurium Besylate Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Cisatracurium Besylate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Cisatracurium Besylate Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Cisatracurium Besylate Injection Sales by Region (2021-2026) & (W Units) Table 42. Global Cisatracurium Besylate Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Cisatracurium Besylate Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Cisatracurium Besylate Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global Cisatracurium Besylate Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Cisatracurium Besylate Injection Sales by Region (2027-2032) & (W Units) Table 47. Global Cisatracurium Besylate Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Cisatracurium Besylate Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Cisatracurium Besylate Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global Cisatracurium Besylate Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Cisatracurium Besylate Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Cisatracurium Besylate Injection Sales by Application (2021-2026) & (W Units) Table 53. Global Cisatracurium Besylate Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Cisatracurium Besylate Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Cisatracurium Besylate Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global Cisatracurium Besylate Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Cisatracurium Besylate Injection Sales by Application (2027-2032) & (W Units) Table 58. Global Cisatracurium Besylate Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Cisatracurium Besylate Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Cisatracurium Besylate Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global Cisatracurium Besylate Injection Price by Application (2027-2032) & (US$/Unit) Table 62. North America Cisatracurium Besylate Injection Sales by Application (2021-2026) & (W Units) Table 63. North America Cisatracurium Besylate Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Cisatracurium Besylate Injection Sales by Application (2021-2026) & (W Units) Table 65. Europe Cisatracurium Besylate Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Cisatracurium Besylate Injection Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Cisatracurium Besylate Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Cisatracurium Besylate Injection Sales by Application (2021-2026) & (W Units) Table 69. Latin America Cisatracurium Besylate Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Cisatracurium Besylate Injection Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Cisatracurium Besylate Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Meitheal Pharmaceuticals Company Information Table 73. Meitheal Pharmaceuticals Business Overview Table 74. Meitheal Pharmaceuticals Cisatracurium Besylate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Meitheal Pharmaceuticals Cisatracurium Besylate Injection Product Portfolio Table 76. Meitheal Pharmaceuticals Recent Development Table 77. AbbVie Company Information Table 78. AbbVie Business Overview Table 79. AbbVie Cisatracurium Besylate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. AbbVie Cisatracurium Besylate Injection Product Portfolio Table 81. AbbVie Recent Development Table 82. Fresenius Kabi Company Information Table 83. Fresenius Kabi Business Overview Table 84. Fresenius Kabi Cisatracurium Besylate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Fresenius Kabi Cisatracurium Besylate Injection Product Portfolio Table 86. Fresenius Kabi Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Cisatracurium Besylate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Cisatracurium Besylate Injection Product Portfolio Table 91. Pfizer Recent Development Table 92. Jiangsu Singchn Company Information Table 93. Jiangsu Singchn Business Overview Table 94. Jiangsu Singchn Cisatracurium Besylate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Jiangsu Singchn Cisatracurium Besylate Injection Product Portfolio Table 96. Jiangsu Singchn Recent Development Table 97. Sandoz Company Information Table 98. Sandoz Business Overview Table 99. Sandoz Cisatracurium Besylate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Sandoz Cisatracurium Besylate Injection Product Portfolio Table 101. Sandoz Recent Development Table 102. Shanghai Sino Biopharma Company Information Table 103. Shanghai Sino Biopharma Business Overview Table 104. Shanghai Sino Biopharma Cisatracurium Besylate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Shanghai Sino Biopharma Cisatracurium Besylate Injection Product Portfolio Table 106. Shanghai Sino Biopharma Recent Development Table 107. Shanghai Hengrui Pharmaceutical Company Information Table 108. Shanghai Hengrui Pharmaceutical Business Overview Table 109. Shanghai Hengrui Pharmaceutical Cisatracurium Besylate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Shanghai Hengrui Pharmaceutical Cisatracurium Besylate Injection Product Portfolio Table 111. Shanghai Hengrui Pharmaceutical Recent Development Table 112. Teva Company Information Table 113. Teva Business Overview Table 114. Teva Cisatracurium Besylate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Teva Cisatracurium Besylate Injection Product Portfolio Table 116. Teva Recent Development Table 117. Xianju Pharma Company Information Table 118. Xianju Pharma Business Overview Table 119. Xianju Pharma Cisatracurium Besylate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Xianju Pharma Cisatracurium Besylate Injection Product Portfolio Table 121. Xianju Pharma Recent Development Table 122. North America Cisatracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 123. North America Cisatracurium Besylate Injection Sales by Country (2021-2026) & (W Units) Table 124. North America Cisatracurium Besylate Injection Sales Market Share by Country (2021-2026) Table 125. North America Cisatracurium Besylate Injection Sales Forecast by Country (2027-2032) & (W Units) Table 126. North America Cisatracurium Besylate Injection Sales Market Share Forecast by Country (2027-2032) Table 127. North America Cisatracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Cisatracurium Besylate Injection Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Cisatracurium Besylate Injection Market Share by Country (2021-2026) Table 130. North America Cisatracurium Besylate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Cisatracurium Besylate Injection Market Share Forecast by Country (2027-2032) Table 132. Europe Cisatracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 133. Europe Cisatracurium Besylate Injection Sales by Country (2021-2026) & (W Units) Table 134. Europe Cisatracurium Besylate Injection Sales Market Share by Country (2021-2026) Table 135. Europe Cisatracurium Besylate Injection Sales Forecast by Country (2027-2032) & (W Units) Table 136. Europe Cisatracurium Besylate Injection Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Cisatracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Cisatracurium Besylate Injection Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Cisatracurium Besylate Injection Market Share by Country (2021-2026) Table 140. Europe Cisatracurium Besylate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Cisatracurium Besylate Injection Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Cisatracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Cisatracurium Besylate Injection Sales by Country (2021-2026) & (W Units) Table 144. Asia-Pacific Cisatracurium Besylate Injection Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Cisatracurium Besylate Injection Sales Forecast by Country (2027-2032) & (W Units) Table 146. Asia-Pacific Cisatracurium Besylate Injection Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Cisatracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Cisatracurium Besylate Injection Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Cisatracurium Besylate Injection Market Share by Country (2021-2026) Table 150. Asia-Pacific Cisatracurium Besylate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Cisatracurium Besylate Injection Market Share Forecast by Country (2027-2032) Table 152. Latin America Cisatracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 153. Latin America Cisatracurium Besylate Injection Sales by Country (2021-2026) & (W Units) Table 154. Latin America Cisatracurium Besylate Injection Sales Market Share by Country (2021-2026) Table 155. Latin America Cisatracurium Besylate Injection Sales Forecast by Country (2027-2032) & (W Units) Table 156. Latin America Cisatracurium Besylate Injection Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Cisatracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Cisatracurium Besylate Injection Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Cisatracurium Besylate Injection Market Share by Country (2021-2026) Table 160. Latin America Cisatracurium Besylate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Cisatracurium Besylate Injection Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Cisatracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Cisatracurium Besylate Injection Sales by Country (2021-2026) & (W Units) Table 164. Middle East and Africa Cisatracurium Besylate Injection Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Cisatracurium Besylate Injection Sales Forecast by Country (2027-2032) & (W Units) Table 166. Middle East and Africa Cisatracurium Besylate Injection Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Cisatracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Cisatracurium Besylate Injection Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Cisatracurium Besylate Injection Market Share by Country (2021-2026) Table 170. Middle East and Africa Cisatracurium Besylate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Cisatracurium Besylate Injection Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Cisatracurium Besylate Injection Distributors List Table 175. Cisatracurium Besylate Injection Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Cisatracurium Besylate Injection Image Figure 2. Global Cisatracurium Besylate Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cisatracurium Besylate Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Cisatracurium Besylate Injection Sales (2021-2032) & (W Units) Figure 5. 2 mg/mL Image Figure 6. Global 2 mg/mL Sales YoY Growth (2021-2032) & (W Units) Figure 7. 5 mg/mL Image Figure 8. Global 5 mg/mL Sales YoY Growth (2021-2032) & (W Units) Figure 9. 10 mg/mL Image Figure 10. Global 10 mg/mL Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Cisatracurium Besylate Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Cisatracurium Besylate Injection Market Share by Type 2025 VS 2032 Figure 13. North America Cisatracurium Besylate Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America Cisatracurium Besylate Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe Cisatracurium Besylate Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Cisatracurium Besylate Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Cisatracurium Besylate Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Cisatracurium Besylate Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Cisatracurium Besylate Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Cisatracurium Besylate Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Cisatracurium Besylate Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Cisatracurium Besylate Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Cisatracurium Besylate Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Clinics Image Figure 26. Global Clinics Sales YoY Growth (2021-2032) & (W Units) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 29. Recovery Center Image Figure 30. Global Recovery Center Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Cisatracurium Besylate Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Cisatracurium Besylate Injection Market Share by Application 2025 VS 2032 Figure 33. North America Cisatracurium Besylate Injection Sales Market Share in Volume by Application in 2025 Figure 34. North America Cisatracurium Besylate Injection Sales Market Share in Value by Application in 2025 Figure 35. Europe Cisatracurium Besylate Injection Sales Market Share in Volume by Application in 2025 Figure 36. Europe Cisatracurium Besylate Injection Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Cisatracurium Besylate Injection Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Cisatracurium Besylate Injection Sales Market Share in Value by Application in 2025 Figure 39. Latin America Cisatracurium Besylate Injection Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Cisatracurium Besylate Injection Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Cisatracurium Besylate Injection Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Cisatracurium Besylate Injection Sales Market Share in Value by Application in 2025 Figure 43. North America Cisatracurium Besylate Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Cisatracurium Besylate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Cisatracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Cisatracurium Besylate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cisatracurium Besylate Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Cisatracurium Besylate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cisatracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Cisatracurium Besylate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cisatracurium Besylate Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Cisatracurium Besylate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cisatracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Cisatracurium Besylate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cisatracurium Besylate Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Cisatracurium Besylate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cisatracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Cisatracurium Besylate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cisatracurium Besylate Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Cisatracurium Besylate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cisatracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Cisatracurium Besylate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Cisatracurium Besylate Injection Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Cisatracurium Besylate Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 2 mg/mL
  • 5 mg/mL
  • 10 mg/mL
Applications
  • Clinics
  • Hospital
  • Recovery Center
Companies covered
  • Meitheal Pharmaceuticals
  • AbbVie
  • Fresenius Kabi
  • Pfizer
  • Jiangsu Singchn
  • Sandoz
  • Shanghai Sino Biopharma
  • Shanghai Hengrui Pharmaceutical
  • Teva
  • Xianju Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cisatracurium Besylate Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cisatracurium Besylate Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cisatracurium Besylate Injection Market by Type
  6. 1.3.1 2 mg/mL
  7. 1.3.2 5 mg/mL
  8. 1.3.3 10 mg/mL
  9. 1.4 Global Cisatracurium Besylate Injection Market Size by Type
  10. 1.4.1 Global Cisatracurium Besylate Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Cisatracurium Besylate Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Cisatracurium Besylate Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Cisatracurium Besylate Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Cisatracurium Besylate Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Cisatracurium Besylate Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Cisatracurium Besylate Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Cisatracurium Besylate Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cisatracurium Besylate Injection Industry Trends
  2. 2.2 Cisatracurium Besylate Injection Industry Drivers
  3. 2.3 Cisatracurium Besylate Injection Industry Opportunities and Challenges
  4. 2.4 Cisatracurium Besylate Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cisatracurium Besylate Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Cisatracurium Besylate Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Cisatracurium Besylate Injection Price (2021-2026)
  4. 3.4 Global Cisatracurium Besylate Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cisatracurium Besylate Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Cisatracurium Besylate Injection Company, Product Type & Application
  7. 3.7 Global Cisatracurium Besylate Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cisatracurium Besylate Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cisatracurium Besylate Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cisatracurium Besylate Injection Tier 1, Tier 2, and Tier 3
4 Cisatracurium Besylate Injection Regional Status and Outlook
  1. 4.1 Global Cisatracurium Besylate Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cisatracurium Besylate Injection Historic Market Size by Region
  3. 4.2.1 Global Cisatracurium Besylate Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cisatracurium Besylate Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cisatracurium Besylate Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cisatracurium Besylate Injection Forecasted Market Size by Region
  7. 4.3.1 Global Cisatracurium Besylate Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cisatracurium Besylate Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cisatracurium Besylate Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cisatracurium Besylate Injection by Application
  1. 5.1 Cisatracurium Besylate Injection Market by Application
  2. 5.1.1 Clinics
  3. 5.1.2 Hospital
  4. 5.1.3 Recovery Center
  5. 5.2 Global Cisatracurium Besylate Injection Market Size by Application
  6. 5.2.1 Global Cisatracurium Besylate Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Cisatracurium Besylate Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Cisatracurium Besylate Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Cisatracurium Besylate Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Cisatracurium Besylate Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Cisatracurium Besylate Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Cisatracurium Besylate Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Cisatracurium Besylate Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Meitheal Pharmaceuticals
  2. 6.1.1 Meitheal Pharmaceuticals Company Information
  3. 6.1.2 Meitheal Pharmaceuticals Business Overview
  4. 6.1.3 Meitheal Pharmaceuticals Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Meitheal Pharmaceuticals Cisatracurium Besylate Injection Product Portfolio
  6. 6.1.5 Meitheal Pharmaceuticals Recent Developments
  7. 6.2 AbbVie
  8. 6.2.1 AbbVie Company Information
  9. 6.2.2 AbbVie Business Overview
  10. 6.2.3 AbbVie Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AbbVie Cisatracurium Besylate Injection Product Portfolio
  12. 6.2.5 AbbVie Recent Developments
  13. 6.3 Fresenius Kabi
  14. 6.3.1 Fresenius Kabi Company Information
  15. 6.3.2 Fresenius Kabi Business Overview
  16. 6.3.3 Fresenius Kabi Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Fresenius Kabi Cisatracurium Besylate Injection Product Portfolio
  18. 6.3.5 Fresenius Kabi Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Cisatracurium Besylate Injection Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Jiangsu Singchn
  26. 6.5.1 Jiangsu Singchn Company Information
  27. 6.5.2 Jiangsu Singchn Business Overview
  28. 6.5.3 Jiangsu Singchn Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Jiangsu Singchn Cisatracurium Besylate Injection Product Portfolio
  30. 6.5.5 Jiangsu Singchn Recent Developments
  31. 6.6 Sandoz
  32. 6.6.1 Sandoz Company Information
  33. 6.6.2 Sandoz Business Overview
  34. 6.6.3 Sandoz Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sandoz Cisatracurium Besylate Injection Product Portfolio
  36. 6.6.5 Sandoz Recent Developments
  37. 6.7 Shanghai Sino Biopharma
  38. 6.7.1 Shanghai Sino Biopharma Company Information
  39. 6.7.2 Shanghai Sino Biopharma Business Overview
  40. 6.7.3 Shanghai Sino Biopharma Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shanghai Sino Biopharma Cisatracurium Besylate Injection Product Portfolio
  42. 6.7.5 Shanghai Sino Biopharma Recent Developments
  43. 6.8 Shanghai Hengrui Pharmaceutical
  44. 6.8.1 Shanghai Hengrui Pharmaceutical Company Information
  45. 6.8.2 Shanghai Hengrui Pharmaceutical Business Overview
  46. 6.8.3 Shanghai Hengrui Pharmaceutical Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Shanghai Hengrui Pharmaceutical Cisatracurium Besylate Injection Product Portfolio
  48. 6.8.5 Shanghai Hengrui Pharmaceutical Recent Developments
  49. 6.9 Teva
  50. 6.9.1 Teva Company Information
  51. 6.9.2 Teva Business Overview
  52. 6.9.3 Teva Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Teva Cisatracurium Besylate Injection Product Portfolio
  54. 6.9.5 Teva Recent Developments
  55. 6.10 Xianju Pharma
  56. 6.10.1 Xianju Pharma Company Information
  57. 6.10.2 Xianju Pharma Business Overview
  58. 6.10.3 Xianju Pharma Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Xianju Pharma Cisatracurium Besylate Injection Product Portfolio
  60. 6.10.5 Xianju Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Cisatracurium Besylate Injection Sales by Country
  2. 7.1.1 North America Cisatracurium Besylate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cisatracurium Besylate Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Cisatracurium Besylate Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cisatracurium Besylate Injection Market Size by Country
  6. 7.2.1 North America Cisatracurium Besylate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cisatracurium Besylate Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Cisatracurium Besylate Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cisatracurium Besylate Injection Sales by Country
  2. 8.1.1 Europe Cisatracurium Besylate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cisatracurium Besylate Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Cisatracurium Besylate Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cisatracurium Besylate Injection Market Size by Country
  6. 8.2.1 Europe Cisatracurium Besylate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cisatracurium Besylate Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cisatracurium Besylate Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cisatracurium Besylate Injection Sales by Country
  2. 9.1.1 Asia-Pacific Cisatracurium Besylate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cisatracurium Besylate Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cisatracurium Besylate Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cisatracurium Besylate Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Cisatracurium Besylate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cisatracurium Besylate Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cisatracurium Besylate Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cisatracurium Besylate Injection Sales by Country
  2. 10.1.1 South America Cisatracurium Besylate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cisatracurium Besylate Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Cisatracurium Besylate Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cisatracurium Besylate Injection Market Size by Country
  6. 10.2.1 South America Cisatracurium Besylate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cisatracurium Besylate Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Cisatracurium Besylate Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cisatracurium Besylate Injection Sales by Country
  2. 11.1.1 Middle East and Africa Cisatracurium Besylate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cisatracurium Besylate Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cisatracurium Besylate Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cisatracurium Besylate Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Cisatracurium Besylate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cisatracurium Besylate Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cisatracurium Besylate Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cisatracurium Besylate Injection Value Chain Analysis
  2. 12.1.1 Cisatracurium Besylate Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cisatracurium Besylate Injection Production Mode & Process
  7. 12.2 Cisatracurium Besylate Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cisatracurium Besylate Injection Distributors
  10. 12.2.3 Cisatracurium Besylate Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst